In our case series, the underlying cause of AML and MPN could be attributed to well-characterized oncogenic drivers other than a single DDX41 variant, suggesting that monoallelic DDX41 variants do not drive the pathophysiology of these myeloid malignancies. This evidence concerns the gene DDX41 and myeloproliferative neoplasm.